BioSpace News Archive

Huiyihuiying, a Chinese hi-tech company that uses big data, artificial intelligence (AI), and radiomics to help radiologists improve diagnostic efficiency and accuracy, announced on November 26 at the Radiological Society of North America’s Annual Meeting (RSNA 2018) the release of two full-cycle AI products worldwide

UCB is excited to be presenting 20 abstracts at this year’s American Epilepsy Society Meeting, taking place between November 30 and December 4 in New Orleans, Louisiana.

Citius Pharmaceuticals, Inc. (“Citius”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on adjunctive cancer care and critical care drug products, announced today that its Executive Chairman, Leonard Mazur, will present at the 11th Annual LD Micro Main Event.

Eureka Therapeutics, Inc., announced today that five abstracts, including four oral presentations and one poster discussion, highlighting clinical programs in multiple myeloma and NHL using binding domains developed by Eureka, have been accepted for presentation at the American Society of Hematology (ASH) Annual Meeting being held December 1-4 in San Diego, California

bluebird bio, Inc. (Nasdaq: BLUE) today announced that the company will host a live webcast of an investor and analyst event being held on Monday, December 3, 2018, during the 60th Annual Meeting of the American Society of Hematology (ASH).

IQVIA Holdings Inc. announced today the pricing of an underwritten, secondary public offering of 6,000,000 shares of its common stock by certain of its existing stockholders, including affiliates of TPG Global, LLC, CPP Investment Board Private Holdings, Inc. and investment funds associated with Bain Capital Investors, LLC at a price to the public of $124.25 per share

Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced the following access information for its investor conference call, to be hosted by President & Chief Executive Officer Joseph Moscato, and his management team Monday, December 3, 2018, at 9:00 a.m. Eastern time:

Alma, one of the top five global leaders of energy-based medical and aesthetic solutions, today announced it has received the Medical Device Single Audit Program (MDSAP) certification, following an audit process to upgrade its quality management system certifications.

Top researchers will present abstracts on latest clinical research advancing cancer treatment options

AbbVie announced today patent license agreements with Pfizer over its proposed biosimilar adalimumab product.